Ebglyss - Lebrikizumab-lbkz 250 mg / 2mL Injection 2 mL
Reference details for licensed healthcare facility review and verification.
| NDC 11 | 00002-7797-61 |
|---|---|
| Product NDC | 00002-7797 |
| Generic Drug Name | lebrikizumab-lbkz |
| Brand Name | Ebglyss |
| Manufacturer | Eli Lilly and Company |
| Strength | 250 mg / 2mL |
| Dosage Form | Injection |
| Drug Type | Subcutaneous |
| Package Quantity | 1 Syringe |
| Package Description | 1 SYRINGE in 1 CARTON (0002-7797-61) / 2 mL in 1 SYRINGE |
| Active Ingredients | Lebrikizumab |
| Marketing Category | BLA |
Unless explicitly stated in writing, no direct affiliation, sponsorship, or endorsement by individual product manufacturers with Premium Rx National, LLC should be implied. All brand names, trade names, and trademarks are the property of their respective owners and are presented solely for accurate product identification and informational reference.
NDC snapshot
lebrikizumab-lbkz 250 mg / 2mL Injection is tracked under NDC 00002-7797-61 and rolls up into product family 00002-7797. Use this page to review package-level identifiers before comparing related family pages or starting a quote review.
- Package configuration: 1 Syringe.
- Manufacturer: Eli Lilly and Company.
- Dosage form: Injection.
- Family size: 2 indexed presentations.
Click a tag to refine the catalog view around this product reference.
Official references
Use official labeling and directory references to confirm presentation details while your team reviews the PRN catalog entry and related sourcing paths.
Alternate presentations in this family
These nearby package-level pages can help healthcare teams compare related packaging or presentation differences inside the same product-NDC family.
Potential alternatives with matching presentation
Open the comparison hub or review package-level listings from 2 product-NDC families with matching normalized presentation details. Review each product detail page before treating any item as a true alternative.
View Potential Alternative Hublebrikizumab-lbkz 250 mg / 2mL Injection 2 mL Syringe4 package-level listings in the comparison hub.Sample package-level pages in this comparison set
Ebglyss - Lebrikizumab-lbkz 250 mg / 2mL Injection 2 mL, NDC 00002-7797-61, is a Eli Lilly and Company 250 mg / 2mL injection presentation packaged as 1 Syringe.
NDC search formats
- Canonical NDC 11: 00002-7797-61
- Digits-only NDC 11: 00002779761
- Possible 10-digit display format: 0002-7797-61 (0002779761)
Helpful product links
- Search by brand name: Ebglyss
- NDC 11: 00002-7797-61
- Product family NDC: 00002-7797
- Compare related presentations: Ebglyss - Lebrikizumab-lbkz 250 mg / 2mL Injection 2 mL